| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.8M | +1134.5% |
| R&D Expense | $12.1M | -5.5% |
| SG&A Expense | $8.5M | -30.7% |
| Operating Income | -$17.9M | +87.4% |
| Pre-tax Income | $9.2M | +105.5% |
| Net Income | $9.2M | +105.5% |
| EPS (Basic) | $0.83 | +102.4% |
| EPS (Diluted) | $0.82 | +102.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $3.8M | +115.0% |
| Current Assets | $8.0M | -68.0% |
| Total Assets | $10.6M | -57.5% |
| Current Liabilities | $11.1M | -3.4% |
| Total Liabilities | $11.2M | -80.1% |
| Stockholders' Equity | -$629K | +98.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.2M | +39.0% |
| Investing Cash Flow | -$2.6M | +29.1% |
| Financing Cash Flow | $3.2M | -90.6% |